drugset / Trial / NCT00990314
Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is an open-label study for patients who participated in the BPS-MR-PAH-203 study and have volunteered to continue treatment for PAH with Beraprost Sodium Modified Release (BPS-MR) tablets.
Timeline
- Start
- 2009-11-30
- Primary completion
- 2013-11-30
- Completion
- 2013-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Beraprost | Small molecule | 60 ug | — |